Related Experiment Video

Updated: Apr 30, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

27.5K

Heart Rhythm Society members' views on pacemaker and implantable cardioverter-defibrillator reuse

Andrew B Hughey1, Nimit Desai, Timir S Baman

  • 1University of Michigan Cardiovascular Center, Ann Arbor, Michigan.

Pacing and Clinical Electrophysiology : PACE
|May 3, 2014
PubMed

Insights

Cardiac implantable electronic device (CIED) reuse is supported by physicians for patients in low- and middle-income countries. Further studies are needed to confirm safety and efficacy of CIED reuse.

Area of Science:

  • Cardiology
  • Medical Device Engineering
  • Global Health

Background:

  • Cardiac implantable electronic devices (CIEDs) are crucial for patient care.
  • Access to new CIEDs is limited in low- and middle-income countries (LMICs).
  • CIED reuse presents a potential solution to address this unmet need.

Purpose of the Study:

  • To assess Heart Rhythm Society (HRS) physicians' perspectives on the reuse of CIEDs.
  • To understand physician attitudes towards safety, ethics, and willingness to participate in CIED reuse programs.

Main Methods:

  • An online survey was distributed to 3,380 HRS physician members.
  • The survey collected data on physicians' opinions regarding CIED resterilization and reimplantation.
  • Response rate was 13% with 429 participants.

Main Results:

  • A significant majority (87%) found CIED resterilization potentially safe, and 88% deemed it ethical if proven safe.
  • 81% of physicians would ask patients to donate devices, and 84% would reimplant if legal.
  • Primary concerns included infection (64%) and device malfunction (29%).
  • Physicians in North America showed more favorable views than those in other high-income countries, but no significant differences were found between high-income and LMICs.

Conclusions:

  • HRS physician members generally support the concept of CIED reuse for underserved populations.
  • Demonstrating clinical efficacy and safety is essential for widespread adoption.
  • Identifying physician-specific barriers to CIED reuse is crucial for implementation.
Abstract

Keywords:
defibrillation-ICDopinionspacingreusereutilizationviews

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.4K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805